106 related articles for article (PubMed ID: 12065653)
1. Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition.
Fodero LR; Sáez-Valero J; McLean CA; Martins RN; Beyreuther K; Masters CL; Robertson TA; Small DH
J Neurochem; 2002 May; 81(3):441-8. PubMed ID: 12065653
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A
Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
Kawarabayashi T; Younkin LH; Saido TC; Shoji M; Ashe KH; Younkin SG
J Neurosci; 2001 Jan; 21(2):372-81. PubMed ID: 11160418
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease.
Sberna G; Sáez-Valero J; Li QX; Czech C; Beyreuther K; Masters CL; McLean CA; Small DH
J Neurochem; 1998 Aug; 71(2):723-31. PubMed ID: 9681463
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology.
Münch G; Apelt J; Rosemarie-Kientsch-Engel ; Stahl P; Lüth HJ; Schliebs R
J Neurochem; 2003 Jul; 86(2):283-9. PubMed ID: 12871569
[TBL] [Abstract][Full Text] [Related]
6. Interaction of exogenous acetylcholinesterase and butyrylcholinesterase with amyloid-β plaques in human brain tissue.
Reid GA; Darvesh S
Chem Biol Interact; 2024 May; 395():111012. PubMed ID: 38648920
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.
Sáez-Valero J; Fodero LR; Sjögren M; Andreasen N; Amici S; Gallai V; Vanderstichele H; Vanmechelen E; Parnetti L; Blennow K; Small DH
J Neurosci Res; 2003 May; 72(4):520-6. PubMed ID: 12704813
[TBL] [Abstract][Full Text] [Related]
8. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease.
Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I
Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex.
Rees T; Hammond PI; Soreq H; Younkin S; Brimijoin S
Neurobiol Aging; 2003 Oct; 24(6):777-87. PubMed ID: 12927760
[TBL] [Abstract][Full Text] [Related]
10. Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology.
Bigl M; Apelt J; Eschrich K; Schliebs R
J Neural Transm (Vienna); 2003 Jan; 110(1):77-94. PubMed ID: 12541014
[TBL] [Abstract][Full Text] [Related]
11. Presence of hydroxysteroid dehydrogenase type 10 in amyloid plaques (APs) of Hsiao's APP-Sw transgenic mouse brains, but absence in APs of Alzheimer's disease brains.
Wen GY; Yang SY; Kaczmarski W; He XY; Pappas KS
Brain Res; 2002 Nov; 954(1):115-22. PubMed ID: 12393239
[TBL] [Abstract][Full Text] [Related]
12. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
13. Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology.
Leal MC; Dorfman VB; Gamba AF; Frangione B; Wisniewski T; Castaño EM; Sigurdsson EM; Morelli L
J Neuropathol Exp Neurol; 2006 Oct; 65(10):976-87. PubMed ID: 17021402
[TBL] [Abstract][Full Text] [Related]
14. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.
Dong H; Csernansky CA; Martin MV; Bertchume A; Vallera D; Csernansky JG
Psychopharmacology (Berl); 2005 Aug; 181(1):145-52. PubMed ID: 15778881
[TBL] [Abstract][Full Text] [Related]
16. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease.
Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I
Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641
[TBL] [Abstract][Full Text] [Related]
17. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.
Sáez-Valero J; Sberna G; McLean CA; Small DH
J Neurochem; 1999 Apr; 72(4):1600-8. PubMed ID: 10098867
[TBL] [Abstract][Full Text] [Related]
18. Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice.
Gau JT; Steinhilb ML; Kao TC; D'Amato CJ; Gaut JR; Frey KA; Turner RS
Am J Pathol; 2002 Feb; 160(2):731-8. PubMed ID: 11839594
[TBL] [Abstract][Full Text] [Related]
19. Presenilin 1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation.
Silveyra MX; Evin G; Montenegro MF; Vidal CJ; Martínez S; Culvenor JG; Sáez-Valero J
Mol Cell Biol; 2008 May; 28(9):2908-19. PubMed ID: 18299393
[TBL] [Abstract][Full Text] [Related]
20. Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology.
Rossner S; Apelt J; Schliebs R; Perez-Polo JR; Bigl V
J Neurosci Res; 2001 Jun; 64(5):437-46. PubMed ID: 11391698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
